PubMed Health⌕ Search

PubMed · 7965310

Connective tissue forces from mandibular advancement.

Abstract

PURPOSE: To quantify the connective tissue forces generated during surgical lengthening of the mandible. PATIENTS AND METHODS: Sixty-three patients who had mandibular advancements by sagittal ramus osteotomy were used in this study. Prior to sectioning the rami, the overjet was recorded. After sectioning the rami, a spring-gauge was attached to the mandibular orthodontic wire and pulled anteriorly to determine how much force was necessary to bring the mandibular incisors into a Class I relationship with the maxillary incisors. Aggressive stripping of the perimandibular periosteum and connective tissues on the distal segment was then performed. The amount of force was again recorded. RESULTS: The mean preoperative overjet in the 63 patients was 6 mm (range, 3 to 11 mm). The mean amount of force required to advance the mandible prior to stripping the tissues was 1,498 g compared with a mean of 787 g after stripping (P < .001). There were statistically significant correlations between the preoperative overjet and the prestripping and poststripping force levels (P < .001). There was also a significant relationship between prestripping and poststripping values (P < .001). CONCLUSION: The results of this study indicate that orthopedic forces are generated by the perimandibular connective tissues following advancement by the mandible. The effect of these forces on the temporomandibular joint should be evaluated in future studies.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E Ellis, D P Sinn. 1994. Connective tissue forces from mandibular advancement.. https://doi.org/10.1016/0278-2391(94)90534-7. https://pubmed.health/record/pubmed%3A7965310/connective-tissue-forces-from-mandibular-advancement

Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.

KEEP EXPLORING

Related citations

A new reconstructive technique for intercalary defects of long bones: the association of massive allograft with vascularized fibular autograft. Long-term results and comparison with alternative techniques.

In 1988, the excellent results obtained with the use of vascularized fibular autograft as a salvage procedure in massive allograft failures caused by non-union or massive resorption prompted a trial of an original reconstructive technique for intercalary defects based on the primary combination of the two types of graft. The authors believe the excellent final results and the ability to avoid further salvage surgical procedures justify the primary application of this more complicated technique despite longer surgical times.

Bone Resorption↗

FSH and bone--important physiology or not?

For many years, osteoporosis in women was equated with estrogen deficiency. The recent articles by Zaidi and colleagues offer a new challenge to the estrogen-deficiency-osteoporosis hypothesis by showing that follicle-stimulating hormone (FSH) stimulates osteoclastic bone resorption perhaps through tumor necrosis factor-alpha (TNF-alpha). These authors, however, neglected to mention bone abnormalities and high testosterone levels that were previously shown in FSH-receptor knockout and other modified mice. It is also possible that they have overemphasized potential relationships of these new data with human bone loss. Despite these fascinating data, the paradigm of FSH causing hypogonadal bone loss is not yet ready to displace the estrogen-deficiency-osteoporosis paradigm, although that model already faces considerable challenge.

Bone Resorption↗

Natural inhibitors targeting osteoclast-mediated bone resorption.

Human cathepsin K, matrix metalloproteinase 9, and alpha(V)beta(3) integrin are the key regulators in osteoclast-mediated bone resorption. In this paper, we found natural inhibitors 1-10 for them by enzyme inhibition assays. Inhibitors 1-7, 8-9, and 10 are novel inhibitors of human cathepsin K, matrix metalloproteinase 9, and alpha(V)beta(3), respectively.

Bone Resorption↗